Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antegrade Dissection and Re-entry Versus Retrograde Strategy in Chronic Total Occlusion Percutaneous Coronary Intervention

NCT06878729 is registered in ClinicalTrials.gov with National Institute of Cardiology, Warsaw, Poland as lead sponsor.

NCT NCT06878729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06878729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antegrade Dissection and Re-entry Versus Retrograde Strategy in Chronic Total Occlusion Percutaneous Coronary Intervention
Lead sponsor
National Institute of Cardiology, Warsaw, Poland
Phase
Not applicable
Overall status
Recruiting
Start date
July 28, 2025
Completion date
September 30, 2028
Enrollment
74 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary occlusion, percutaneous coronary intervention